210 related articles for article (PubMed ID: 36277576)
1. Recurrent Leflunomide-Induced Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Syndrome Despite Prolonged Steroid Taper: A Case Report.
Gayfield S; Busken J; Mansur S
Cureus; 2022 Sep; 14(9):e29319. PubMed ID: 36277576
[TBL] [Abstract][Full Text] [Related]
2. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
3. An Uncommon Presentation of DRESS Syndrome Secondary to Leflunomide Use: A Case Report.
Rao S; Sunkara A; Srivastava N; Sampat P; Ramos C; Albert E
J Investig Med High Impact Case Rep; 2021; 9():2324709621997282. PubMed ID: 33629602
[TBL] [Abstract][Full Text] [Related]
4. Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.
Hyser E
J Med Case Rep; 2022 Sep; 16(1):336. PubMed ID: 36059007
[TBL] [Abstract][Full Text] [Related]
5. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
Oelze LL; Pillow MT
J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
7. Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM; Chikova IA; Kostik MM
Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
[TBL] [Abstract][Full Text] [Related]
8. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
[TBL] [Abstract][Full Text] [Related]
9. DRESS syndrome: quetiapine associated case report and literature review.
Mallaro HL; Rosenthal LJ
Int Clin Psychopharmacol; 2023 Sep; 38(5):356-360. PubMed ID: 37159165
[TBL] [Abstract][Full Text] [Related]
10. DRESS syndrome in the setting of oxacillin therapy-a call for better patient preparedness: a case report.
Abu HO; Ali SMJ; Phuyal A; Sherif A; Williams GT; Chastain I
J Med Case Rep; 2021 Dec; 15(1):613. PubMed ID: 34955100
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.
Gómez-Zorrilla S; Ferraz AV; Pedrós C; Lemus M; Peña C
Ann Pharmacother; 2012; 46(7-8):e20. PubMed ID: 22764327
[TBL] [Abstract][Full Text] [Related]
12. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
13. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: Retrospective Cohort Study.
Zita S; Broussard L; Hugh J; Newman S
JMIR Dermatol; 2023 Jul; 6():e41391. PubMed ID: 37632913
[TBL] [Abstract][Full Text] [Related]
15. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
16. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis treatment of vancomycin-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome in a patient undergoing peritoneal dialysis.
Mitsuno R; Nakayama T; Uchiyama K; Yoshimoto N; Kusahana E; Morimoto K; Yoshino J; Yoshida T; Kanda T; Yamaguchi S; Hayashi K
CEN Case Rep; 2024 Feb; ():. PubMed ID: 38337109
[TBL] [Abstract][Full Text] [Related]
18. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.
De A; Rajagopalan M; Sarda A; Das S; Biswas P
Indian J Dermatol; 2018; 63(1):30-40. PubMed ID: 29527023
[TBL] [Abstract][Full Text] [Related]
19. Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin.
Singh J; Dinkar A; Atam V; Gupta KK; Sahani KK
J Res Pharm Pract; 2016; 5(1):70-3. PubMed ID: 26985439
[TBL] [Abstract][Full Text] [Related]
20. Anti-tubercular therapy causing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
Saxena P; Chadha D; Goyal R
J R Coll Physicians Edinb; 2020 Dec; 50(4):414-415. PubMed ID: 33469620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
